Home AFPI KGMOA Contact

Coronavirus Disease 2019 - COVID 19

COVID-19: Library

Resources on coronavirus disease (COVID-19)
BMJ
Cambridge University Press
Centers for Disease Control and Prevention
Chinese Medical Association
Cochrane
Elsevier
European Centre for Disease Prevention and Control (ECDC)
JAMA Network
The Lancet
LITCOVID: US National Library of Medicine
New England Journal of Medicine
Oxford University Press
PLOS
Science
Springer Nature
SSRN (Preprints)
Wiley
Date Agency Description
- BioWorld Bergenbio’s bemcentinib joins fast-tracked Accord program targeting COVID-19
- WHO “Solidarity” clinical trial for COVID-19 treatments
- WHO COVID-19 Emergency Use Listing Procedure (EUL)
- WHO International Clinical Trials Registry Platform
- WHO Update on research activities for novel coronavirus
- WHO WHO COVID-19 Database
04/04/20 Intensive Care Society ICS Guidance for Prone Positioning of the Conscious COVID Patient 2020
04/04/20 The New Englad Journal of Medicine Clinical Outcomes of Hydroxychloroquine in Hospitalized Patients with COVID-19: A Quasi-Randomized Comparative Study
07/04/20 AIIMS - New Delhi Guidelines for Re-Use of Personal Protective Equipment
03/04/20 AIIMS - New Delhi Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
25/03/20 CMC Vellore Protocol for use of HCQS for COVID 19 prophylaxis
19/03/20 Cell Press Journal Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
18/03/20 Nature.com Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
03/04/20 Science Direct The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro
11/03/20 US National Library of Medicine Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting (COPCOV)

©   All rights reserved 2020.    Contact us at admin@afpikerala.in
Designed by Dr. Serin Kuriakose

Hits: web counter